Abstract
Similar to SARS and MERS, the host immune response to COVID-19 is implicated in the severity of the disease itself. Here, we investigate the possible use of scoring systems to help guide clinicians in their determination as to when to commence immunosuppressive treatment in COVID-19. We utilized the relatively established clinical and biochemical severity indicators from large cohort studies to develop a potential scoring system for the hyperimmune response in COVID-19.
Author supplied keywords
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for freeCite
CITATION STYLE
APA
Goyal, D. K., & Mansab, F. (2020). The CHIR Score for Evaluating the Hyperimmune Response in COVID-19: A Preliminary Concept. Frontiers in Public Health, 8. https://doi.org/10.3389/fpubh.2020.550933
Readers over time
Readers' Seniority
Readers' Discipline
